Dadar West, Mumbai, Maharashtra
GST No. 27AAFCD4677G1ZF
Call 08048963615 78% Response Rate
Pharmaceutical products – more commonly known as medicines or drugs – are a fundamental component of both modern and traditional medicine. We want to discover, develop and successfully market innovative products to of new state-of-the-art pharmaceutical.
Minimum Order Quantity: 10000 Piece
Packaging Type | Bottle |
Packaging Size | 500 ml |
Product Type | Finished Product |
Form | Liquid |
Usage | Personal, Commercial, Clinical, Hospital |
Dextrose and Sodium Chloride Injections USP are sterile, nonpyrogenic and contain no bacteriostatic or antimicrobial agents. These products are intended for intravenous administration.
Indications and Usage for Dextrose and Sodium Chloride Injection
Contraindications:
View Complete details
Packaging Type | Strips |
Type Of Medicines | Allopathic |
Usage | Hospital,Clinic |
Packaging Size | 10X10 Tablets |
Strength | 20 mg |
View Complete details
Packaging Type | Glass Bottle |
Packaging Size | 10 ml |
Medicine Type | Allopathic |
Usage | Hospital,Clinical |
Strength | 1000 mcg |
View Complete details
Packaging Type | Glass Bottle |
Packaging Size | 1 ml |
Medicine Type | Allopathic |
Usage | Hospital,Clinical |
Strength | 50 mcg |
View Complete details
Minimum Order Quantity: 10000 Piece
Packaging Type | Bottle |
Packaging Size | 500ml |
Form | Liquid |
Usage | Commercial, Hospital, Personal, Clinical |
View Complete details
Usage | Personal, Hospital |
Dose | 1ml-5ml |
Packaging Type | Glass Bottle |
Medicine Type | Allopathic |
View Complete details
Packaging Type | Bottle |
Dose/Strength (ex. 1 mg or 1 ml) | 10 Doses |
Usage | Hospital, Clinical |
Form | Liquid |
View Complete details
Usage | Clinical, Personal |
Packaging Type | 12 gms,120 metered actuations |
Strength | 250mg |
View Complete details
Packaging Size | 20 x 10 Tablets |
View Complete details
Brand | Remicade |
Strength / Dose | 100 mg |
Packaging Size | 1 vial |
Manufacturer | Janssen |
Composition | Infliximab 100mg |
Packaging type | Vial |
Treatment | Arthritic |
Usage | Hospital,Clinic |
View Complete details
Minimum Order Quantity: 10 bottle
Packaging Size | 28 TABLET |
Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
Treatment | hepatitis C virus (HCV) infection |
Prescription/Non prescription | Non prescription |
Form | Tablet |
Dosage Form | Tablet |
Packaging Type | 28 Tablets |
Strength | Sofosbuvir (400mg) + Velpatasvir (100mg) |
Additional Information:
View Complete details
Packaging Size | 1*10 (10 Tablets) |
Packaging Type | Alu-Alu |
Brand | BRIXCEE |
Key Ingredient | CHEWABLE |
Usage / Application | IMMUNIZER |
Form | Tablet |
Prescription/Non prescription | Non prescription |
Manufacturer | Brixbio pharma pvt ltd |
View Complete details
Minimum Order Quantity: 2 Box
Strength | 80mg |
Packaging Size | 1*10 Tablet |
Brand | Tagrisso 80mg |
Composition | OSIMERTINIB |
Manufacturer | Astrazeneca |
Treatment | LUNG CANCER |
Prescription/Non prescription | Non Prescription |
Form | Tablet |
Additional Information:
View Complete details
Prescription/Non prescription | Prescription |
Usage/Application | Commerical |
Grade Standard | Technical Grade |
CAS Number | 83905-01-5 |
Physical State | Powder |
Dosage Form | Syrup, Injection, Capsule, Tablet, Powder |
Form | Tablet |
Solubility | 0.514 mg/mL |
Molecular Weight | 785.026 g/mol |
Assay | NOT MORE THAN 98% |
Type Of API | GENERIC |
Chemical Name | Azadose Ribotrex |
Chemical Formula | C38H76N2O14 |
Iupac Name | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl |
Molecular Formula | C38H76N2O14 |
Additional Information:
Item Code: 117772-70-0
View Complete details
Usage | Hospital, Clinical |
Packaging Size | 30 Tablets |
Packaging Type | Bottle |
Form | Tablet |
Strength | 250mg |
View Complete details
Usage | Commercial, Hospital, Personal, Clinical |
Packaging Type | Tube |
Packaging Size | 30 g |
Phenytoin Sodium | 1% w/w |
Mechanism of action:
The mechanism by which phenytoin accelerates wound healing is unknown. Clinical, animal and in vitro studies suggest that phenytoin may be involved in the healing process at several levels including stimulating fibroblast proliferation, enhancing the formation of granulation tissue, decreasing collagenase activity (by reducing its production for secretion or both), promoting deposition of collagen and other connective tissue components, decreasing bacterial contamination, and decreasing wound exudates. Biopsies of phenytoin treated open wounds show neovascularization, collagenization and decreased polymorphonuclear and eosinophil cell infiltration. A number of clinical studies indicate that phenytoin decreases the bacterial load of wounds. Topical phenytoin was reported to eliminate Staphylococcus aureus, E. coil, Klebsiella spp. And Pseudomonas spp. from wounds within 7-9 days. Phenytoin more readily cleared gram negative organisms than gram positive bacteria form wounds.
Local pain relief has also been observed with topical phenytoin therapy , which topical phenytoin therapy , which can be explained by its membrane stabilizing action; the reduced inflammatory response may also contribute. Facilitation of nerve regeneration has also been reported with phenytoin .
Indications:
Topical phenytoin has proven useful for a wide variety of soft tissue wounds. Some of these include leprosy trophic ulcers, decubitus ulcers, diabetic foot ulcers, burns, traumatic wounds, venous stasis ulcers and abscesses. Topical phenytoin also appears to be potentially useful in epidermolysis bullosa simplex.
Contraindications:
Side Effects:
Additional Information:
View Complete details
Minimum Order Quantity: 10000 Piece
Packaging Size | 500 ml |
Packaging Type | Bottle |
Form | Liquid |
Usage | Hospital,Clinical |
5% Dextrose Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing dextrose in water for injection intended for intravenous administration.
Each 100 mL of 5% Dextrose Injection, USP, contains dextrose monohydrate, 5 g in water for injection. The caloric value is 170 kcal/L. The osmolarity is 252 mOsmol/L (calc.), which is slightly hypotonic.
his solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded.
5% Dextrose Injection, USP is a parenteral fluid and nutrient replenisher.
Dextrose, USP is chemically designated D-glucose monohydrate (C6H12O6 • H2O), a hexose sugar freely soluble in water. It has the following structural formula:
Water for Injection, USP is chemically designated H2O.
The flexible container is fabricated from a specially formulated non-plasticized film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container’s chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
View Complete details
Packaging Type | Box |
Usage | Hospital, Clinical |
Packaging Size | 30 Tablets |
Strength | 500mg |
Preparations:
Storage:
Prescribed For:
Dosing:
View Complete details
Usage | Clinical, Personal |
Packaging Size | 20g |
Packaging Type | Tube |
Form | Cream |
View Complete details
Packaging Size | 10*10 Box (100 Tablets) |
Dosage | 100mg |
Packaging Type | Blister |
Form | Tablet |
View Complete details
Composition | Vitamin C |
Manufacturer Name | BRIX BIO PHARMA PVT LTD |
Form | Injection |
Prescription/Non prescription | Non prescription |
View Complete details
Packaging Type | Box |
Usage | Hospital, Clinical |
Form | Liquid |
View Complete details
Packaging Size | 5 x 10 Tablets |
View Complete details
Packaging Type | Vial |
Packaging Size | 1 X 14ML |
Brand | Prejeta 420mg |
Prescription Required | Yes |
Country of Origin | Made in India |
View Complete details
Minimum Order Quantity: 50 PER STRIP OF 10 TABLET
Pack size | 10 TABLET |
Usage/Application | TABLET |
Grade Standard | GENERIC |
CAS Number | 15687-27-1 |
Physical State | Powder |
Dosage Form | Tablet, Powder |
Packaging Type | 100 TABLET IN BOX |
Form | Tablet |
Generic Name | Brufen |
Prescription/Non prescription | Prescription |
Color | White powder |
Solubility | 0.0684 mg/mL |
Molecular Weight | 206.2808 |
Assay | Not more than 99% |
Type Of API | Generic |
Chemical Name | Brufen Motrin |
Chemical Formula | C13H18O2 |
Iupac Name | 2-[4-(2-methylpropyl)phenyl]propanoic acid |
Molecular Formula | C13H18O2 |
View Complete details
Usage | Commercial, Clinical, Hospital |
Packaging Size | 30 G |
Strength | 10 Mg |
Packaging Type | Tube |
View Complete details
Packaging Size | 3ml |
Packaging Type | Bottle |
Usage | Clinical, Hospital |
Strength | 60mg |
View Complete details
Packaging Type | Box |
Packaging Size | 10X2X2 ml |
Usage | Clinical, Hospital |
Strength | 4mg |
View Complete details
Dose/Strength (ex. 1 mg or 1ml) | 500 mg |
Packaging Size | 5 x 10 Tablets |
Packaging Type | Strip |
Usage | Clinical, Hospital, Personal |
Additional Information:
View Complete details
Dose | 500 mg |
Usage | Clinical, Hospital, Personal |
Packaging Size | 5 x 10 Tablet |
Packaging Type | Strip |
View Complete details
Pack size | 25Units |
Prescription/Non prescription | Prescription |
Usage/Application | Industrial |
Grade Standard | Analytical Grade |
Packaging Size | Drum |
CAS Number | 93-14-1 |
Physical State | Powder |
Packaging Type | Drum |
Color | WHITE TO SLIGHTLY GRAY |
Solubility | 50000 |
Molecular Weight | 50000 |
Chemical Formula | 3-(2-methoxyphenoxy)propane-1,2-diol |
Iupac Name | 3-(2-methoxyphenoxy)propane-1,2-diol |
Molecular Formula | C10H14O4 |
View Complete details
Pack size | 25kg |
Prescription/Non prescription | Prescription |
CAS Number | 14484-47-0 |
Physical State | Powder |
Product Type | API |
Packaging Type | Drum |
Form | Powder |
Grade Standard | Pharmaceutical |
Solubility | Test freely soluble in acetic acid,methylene chloride,slightly soluble in ethanol,acetone,meth |
Molecular Weight | C25H31NO6 |
Assay | 97.0%~102.0% |
Type Of Medicines | Anti-Inflammatory and immunosuppressant |
Chemical Formula | C25H31NO6 |
Color | White |
Molecular Formula | C25H31NO6 |
Usage/Application | Clinical |
Drug Name | Deflazacort |
Molecular Formula: C25H31NO6
Molecular Weight: 441.52
CAS: 14484-47-0
Function and usage:
Deflazacort is derived from prednisolone, a systemic corticosteroids.
Appearance: white or almost white powder
Solubility test Freely soluble in acetic acid, methylene chloride, slightly
soluble in ethanol, acetone,
methanol, insoluble in water
Assay 97.0%~102.0%
SPECIFICATION Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. Deflazacort is an inactive prodrug which is metabolized rapidly to the active drug 21-desacetyldeflazacort. Its potency is around 70–90% that of prednisone.
Storage Store in a well-closed container away from moisture
Deflazacort, also known as Emflaza, is a corticosteroid prodrug used as an agent to manage Duchenne Muscular Dystrophy (DMD). It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.14,Label
Duchenne Muscular Dystrophy is an inherited disorder resulting from mutations of the dystrophin gene, which is important for muscle function. This disease can cause serious muscle weakness and progressive breathing and cardiovascular disability, severely impacting patient quality of life and survival.3,4,15 This disease usually manifests by muscle weakness in early childhood followed by loss of the ability to walk (ambulation) as early as age 7.4
Deflazacort delays the onset of muscle related complications resulting from DMD6, prolonging the lives of children diagnosed with this disease and exerting less harmful effects on the bone health and weight than other steroid medications.
Additional Information:
Item Code: 14484-47-0
View Complete details
Packaging Size | 10 X 1ml Ampoules |
Packaging Type | Box |
Usage | Hospital, Clinical |
View Complete details
Usage | Hospital,Clinic,Personal |
View Complete details
Drug Name | Ofloxacin |
Dosage Form | Powder |
Packaging Size | 25kg |
Packaging Type | Drum |
Color | White |
View Complete details
Packaging Size | 100mg |
View Complete details